Extensive article published in Sunday’s issue of ARA on the research line developed by Meritxell Teixidó in Ernest Giralt’s lab to extract natural poison from bees, scorpions and spiders, which provides peptides able to cross the blood-brain barrier. Many drugs cannot enter the brain because of this barrier, which serves to protect this organ against infections. Several projects at IRB Barcelona seek to find and modify natural peptide venoms that have the capacity to cross this barrier without damaging it, in order to use them as drug transporters into the brain.
Coverage in the media of the 25th Barcelona BioMed Conference on membrane proteins—molecules that account for 30% of the human genome. To date, the atomic structures of only 3% of these proteins are known from an estimated 15,000. More than 50% of current drugs target membrane proteins, thus indicating the immense therapeutic potential for relevant functions that cells undertake.
In a conference organised by the Fundación BBVA and IRB Barcelona in Barcelona, 150 international scientists are brought together to debate membrane protein functions, atomic resolution techniques...
The newspaper El Correo, edited in Vizcaya, publishes a whole-page article on the link between the brain and the liver with respect to appetite control.
The study, which was performed in the "Metabolic engineering and diabetes therapy” lab, headed by Joan J. Guinovart, has been widely echoed in the media.
Read the article in El Confidencial: ¿Comes mucho y no te sacias? En tu hígado puede estar la respuesta
Extensive report on three "crowdfunding" initiatives, among them one led by the company Iproteos, co-funded by researchers at IRB Barcelona.
ARA publishes an article on the success of IRB Barcelona’s dance video. The director of the institute explains the importance of the awareness and fund-raising campaign and emphasizes that "people should know that, other than the taxes that they pay, they can also channel donations into research on a topic of interest to them, because it affects them and because it worries them."
Extensive article about the various research projects undertaken by Ernest Giralt’s group at IRB Barcelona. The article focuses on those devoted to the design of peptides with the capacity to cross the blood-brain barrier. “I think we are the only group worldwide studying the use of poisons as transporters of new drugs into the brain,” explains Ernest Giralt, full professor of the UB and coordinator of the Chemistry and Molecular Pharmacology Programme at IRB Barcelona.
La Opinión de Zamora publishes an article on research conducted by Angel Rodríguez Nebreda, ICREA researcher at IRB Barcelona, on the functions of p53 in breast and colon tumours. Nebreda presented the results on the protein kinase p38 MAPKs in the Centro de Investigación del Cáncer de Salamanca.
TV3’s programme "Divendres" holds a 20-minute interview with Salvador Aznar Benitah, ICREA researcher at IRB Barcelona. During the interview, Aznar Benitah, who studies stem cells and cancer, explains the use and potential applications of stem cells.
Carme Cortina, Eduard Batlle, and Joan Guinovart have been interviewed on “Els Matins” on TV3 regarding the success of the dance video that IRB launched on 13 October, which has received 830,000 visits to date. They also explained the benefits of research and the need for society to support science and went on to talk about some of the research lines being conducted at IRB Barcelona.
The study by Jordi Casanova and first-authored by postdoctoral fellow Nareg J.-V. Djabrayan at IRB Barcelona, together with researchers at CSIC, has been echoed in the media.